microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements by Alexander Schwickert (835514)

“…Supported by transcriptomic Affymetrix array analysis and confirmatory investigations at the mRNA and protein level, we demonstrate that overexpression of miR-142-3p in MDA-MB-231, MDA-MB-468 and MCF-7 breast cancer cells leads to downregulation of <i>WASL</i> (Wiskott-Aldrich syndrome-like, protein: N-WASP), Integrin-αV, <i>RAC1</i>, and <i>CFL2</i>, molecules implicated in cytoskeletal regulation and cell motility. …”

Emission spectra of S100A1 fluorescence titrations exhibiting decreasing fluorescence intensities with increasing concentration of S100B at the μM level. by Md. Imran Khan (4853302)

() Cyclic voltammogram for blank, HS-NTA coated step, Ni-NTA coated step and MutS immobilized step in the presence of 5 mM by Minseon Cho (63333)

“…After immobilization of HS-NTA, is increased (open diamond), then formation of Ni-NTA complex causes a decrease of . After immobilization of protein, is re-increased due to interference degree of for the condition of electrode surface. () Blank in the presence of 5 mM . () Cyclic voltammogram and () Nyquist plots measured after the reaction of AT homoduplex and GT heteroduplex. …”

The major role of <i>sarA</i> in limiting <i>Staphylococcus aureus</i> extracellular protease production <i>in vitro</i> is correlated with decreased virulence in diverse clinical... by Mara J. Campbell (14579826)

Effect of exogenous ERα expression on the ability of Wnt-5a to decrease breast cancer cell invasion. by Janna Sand-Dejmek (449584)

DataSheet_1_UFR2709, a Nicotinic Acetylcholine Receptor Antagonist, Decreases Ethanol Intake in Alcohol-Preferring Rats.docx by Gabriel Quiroz (8068676)

Kcnk5b activity induces IP₃R-mediated Ca²⁺ release from the ER. by Xiaowen Jiang (8291814)

Manganase²⁺ stimulation decreases association of ADAM17 to β1 integrin and leads to increased ADAM17 activity. by Pal Gooz (330154)

Treatment with the antioxidant <i>N</i>-Acetyl-L-Cysteine (NAC) or with the p53 inhibitor, Pifithrin-α (PFT), prevents ROS formation in hMp84-overexpressing A375 cells. by Daniele Moretti (379766)

Fig 1 - by Stephanie L. Samani (17896610)

Table_1_HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?.docx by Alejandro G. García-Ruiz de Morales (16445565)

“…Background<p>Missed opportunities for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) testing remain high. We aimed to ascertain the knowledge of screening guidelines and attitudes of non-infectious disease (ID) hospital physicians and assess the impact of a 1-h session on screening rates and diagnoses.…”

Image_3_Evaluation of Live Bacterial Prophylactics to Decrease IncF Plasmid Transfer and Association With Intestinal Small RNAs.tif by Graham A. J. Redweik (5648027)

Table_3_Evaluation of Live Bacterial Prophylactics to Decrease IncF Plasmid Transfer and Association With Intestinal Small RNAs.xlsx by Graham A. J. Redweik (5648027)

Image_2_Evaluation of Live Bacterial Prophylactics to Decrease IncF Plasmid Transfer and Association With Intestinal Small RNAs.tif by Graham A. J. Redweik (5648027)

Image_1_Evaluation of Live Bacterial Prophylactics to Decrease IncF Plasmid Transfer and Association With Intestinal Small RNAs.tif by Graham A. J. Redweik (5648027)

Table_1_Evaluation of Live Bacterial Prophylactics to Decrease IncF Plasmid Transfer and Association With Intestinal Small RNAs.docx by Graham A. J. Redweik (5648027)

Table_2_Evaluation of Live Bacterial Prophylactics to Decrease IncF Plasmid Transfer and Association With Intestinal Small RNAs.docx by Graham A. J. Redweik (5648027)

Treatment with the antioxidant <i>N</i>-Acetyl-L-Cysteine (NAC) or with the p53 inhibitor, Pifithrin-α (PFT), prevents cell death in hMp84-overexpressing A375 cells. by Daniele Moretti (379766)

Image_2_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

“…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). The number of patients who received any opioids decreased from 84.2% (16/19) before implementation to 23.1% (3/13) after implementation.…”

Image_1_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

“…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). The number of patients who received any opioids decreased from 84.2% (16/19) before implementation to 23.1% (3/13) after implementation.…”